Related references
Note: Only part of the references are listed.Hypoxia Inducible Factor Stabilization As a Novel Strategy to Treat Anemia
S. Zhao et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Peginesatide for Anemia in Patients with Chronic Kidney Disease Not Receiving Dialysis
Iain C. Macdougall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Peginesatide in Patients with Anemia Undergoing Hemodialysis
Steven Fishbane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Erythropoietin
H. Franklin Bunn
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
New Anemia Therapies: Translating Novel Strategies From Bench to Bedside
Iain C. Macdougall
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Absorption, distribution, metabolism and excretion of peginesatide, a novel erythropoiesis-stimulating agent, in rats
Kathryn W. Woodburn et al.
XENOBIOTICA (2012)
Profile of peginesatide and its potential for the treatment of anemia in adults with chronic kidney disease who are on dialysis
Ashraf Mikhail
JOURNAL OF BLOOD MEDICINE (2012)
Significant further evidence to bolster the link between epoetin and strokes in chronic kidney disease and cancer
David J. Goldsmith et al.
KIDNEY INTERNATIONAL (2011)
Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease
Suetonia C. Palmer et al.
ANNALS OF INTERNAL MEDICINE (2010)
Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes
J. Glaspy et al.
BRITISH JOURNAL OF CANCER (2010)
2009: A Requiem for rHuEPOs-But Should We Nail Down the Coffin in 2010?
David Goldsmith
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer
J. Douglas Rizzo et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Iron-Deficiency Anemia in Castleman Disease: Implication of the Interleukin 6/Hepcidin Pathway
Jean-Benoit Arlet et al.
PEDIATRICS (2010)
Hypoxic regulation of erythropoiesis and iron metabolism
Volker H. Haase
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis
Marcello Tonelli et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia
David E. Leaf et al.
KIDNEY INTERNATIONAL (2009)
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
Julia Bohlius et al.
LANCET (2009)
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
Marc A. Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Update on Erythropoiesis-Stimulating Agents and Clinical Trials in Oncology
Matti Aapro et al.
ONCOLOGIST (2009)
Erythropoietins: A common mechanism of action
Steve Elliott et al.
EXPERIMENTAL HEMATOLOGY (2008)
CERA: third-generation erythropoiesis-stimulating agent
Joel Michels Topf
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia
Charles L. Bennett et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Use of epoetin and darbepoetin in patients with cancer: 2007 American society of clinical oncology/American society of hematology clinical practice guideline update
J. Douglas Rizzo et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Stimulating erythropoiesis: Future perspectives
Ashraf Mikhail et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2008)
Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis
Arintaya Phrommintikul et al.
LANCET (2007)
Correction of anemia with epoetin alfa in chronic kidney disease
Ajay K. Singh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Update on erythropoietin treatment: Should hemoglobin be normalized in patients with chronic kidney disease?
Ernesto Paoletti et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Ex vivo transduction of human dermal tissue structures for autologous implantation production and delivery of therapeutic proteins
E Brill-Almon et al.
MOLECULAR THERAPY (2005)
Pure red-cell aplasia and epoetin therapy
CL Bennett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy:: randomised, double-blind, placebo-controlled trial
M Henke et al.
LANCET (2003)
Breast cancer trial with erythropoietin terminated unexpectedly
B Leyland-Jones
LANCET ONCOLOGY (2003)
Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.
N Casadevall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
A comparison between epoetin omega and epoetin alfa in the correction of anemia in hemodialysis patients: A prospective, controlled crossover study
A Bren et al.
ARTIFICIAL ORGANS (2002)
Share Paper
